Antony Loebel

Antony Loebel

No open positions remaining

Net worth: 476 181 $ as of 31/08/2026

66 year
Health Technology
Consumer Services
Finance

Profile

Antony Loebel is currently Director at Pharmaceutical Research & Manufacturers of America, Director at Sunovion Pharmaceuticals Europe Ltd. since 2019, Director at HighCape Capital Acquisition Corp.
II, Assistant Professor at New York University School of Medicine, Advisor at HighCape Partners Management LLC, and Chief Medical Officer at Seaport Therapeutics, Inc. since 2024.
Former positions include Director at Pfizer Inc. from 2006 to 2007, Director, Chief Medical Officer & Executive VP at Sumitomo Pharma America, Inc. from 2007 to 2019, Director at Massachusetts Biotechnology Council, and Independent Director at HighCape Capital Acquisition Corp.
from 2020 to 2021.
Education includes undergraduate studies at the University of Washington and a doctorate from UW Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.04%
04/05/2026 20,109 ( 0.04% ) 476 181 $ 31/08/2026

Antony Loebel active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member 01/04/2019
Consultant / Advisor -

Former positions of Antony Loebel

CompaniesPositionEnd
HIGE CAPI Director/Board Member 10/06/2021
PFIZER INC. Director/Board Member 01/01/2007
Director/Board Member -
Chief Executive Officer -
See the detail of Antony Loebel's experience

Training of Antony Loebel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Finance

Health Technology

Finance

Finance